Assessment of bone marrow involvement in patients with lymphoma: report on a consensus meeting of the Korean Society of Hematology Lymphoma Working Party
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
In September 2011, the Korean Society of Hematology Lymphoma Working Party held a nationwide conference to establish a consensus for assessing bone marrow (BM) involvement in patients with lymphoma. At this conference, many clinicians, hematopathologists, and diagnostic hematologists discussed various topics for a uniform consensus in the evaluation process to determine whether the BM is involved. Now that the discussion has matured sufficiently to be published, we herein describe the consensus reached and limitations in current methods for assessing BM involvement in patients with lymphoma.
Abstract
In September 2011, the Korean Society of Hematology Lymphoma Working Party held a nationwide conference to establish a consensus for assessing bone marrow (BM) involvement in patients with lymphoma. At this conference, many clinicians, hematopathologists, and diagnostic hematologists discussed various topics for a uniform consensus in the evaluation process to determine whether the BM is involved. Now that the discussion has matured sufficiently to be published, we herein describe the consensus reached and limitations in current methods for assessing BM involvement in patients with lymphoma.
참고문헌 (40)
- Zhang QY, "Bone marrow involvement by hodgkin and non-hodgkin lymphomas", Hematol Oncol Clin North Am, 23, pp.873~902 (2009)
- Carbone PP, "Report of the committee on Hodgkin’s disease staging classification", Cancer Res, 31, pp.1860~1861 (1971)
- Lister TA, "Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds meeting", J Clin Oncol, 7, pp.1630~1636 (1989)
- Hoppe RT, "Hodgkin lymphoma", J Natl Compr Canc Netw, 9, pp.1020~1058 (2011)
- Zelenetz AD, "NCCN clinical practice guidelines in oncology: non-Hodgkin’s lymphomas", J Natl Compr Canc Netw, 8, pp.288~334 (2010)
- Bayraktar S, "Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients", Br J Haematol, 152, pp.72~80 (2011)
- Oh SY, "Stage IV marginal zone B-cell lymphoma: prognostic factors and the role of rituximab. Consortium for Improving Survival of Lymphoma (CISL) study", Cancer Sci, 101, pp.2443~2447 (2010)
- Thieblemont C, "Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed", Blood, 95, pp.802~806 (2000)
- "The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin’s lymphoma", N Engl J Med, 329, pp.987~994 (1993)
- Stiff PJ, "Autologous transplantation as consolidation for aggressive non-Hodgkin’s lymphoma", N Engl J Med, 369, pp.1681~1690 (2013)
- 윤재호, "Role of frontline autologous stem cell transplantation in young, high-risk diffuse large B-cell lymphoma patients", The Korean Journal of Internal Medicine, 30(3), pp.362~371 (2015), 대한내과학회[DOI]
- Foucar K, "Bone Marrow Pathology" (2010), American Society for Clinical Pathology Press
- Rozman C, "Chronic lymphocytic leukemia", N Engl J Med, 333, pp.1052~1057 (1995)
- Montserrat E, "Bone marrow assessment in B-cell chronic lymphocytic leukaemia: aspirate or biopsy? A comparative study in 258 patients", Br J Haematol, 93, pp.111~116 (1996)
- 전영우, "Chronic lymphocytic leukemia: a clinical review including Korean cohorts", The Korean Journal of Internal Medicine, 31(3), pp.433~443 (2016), 대한내과학회
- Fend F, "Diagnosis and classification of malignant lymphoma and related entities in the bone marrow trephine biopsy", Pathobiology, 74, pp.133~143 (2007)
- Foucar K, "Diagnostic Pathology:Blood and Bone Marrow" (2012), Amirsys Pub.
- Brown D, "Bone Marrow Diagnosis: An Illustrated Guide" (2006), Blackwell
- Alizadeh AA, "Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling", Nature, 403, pp.503~511 (2000)
- Hans CP, "Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray", Blood, 103, pp.275~282 (2004)
- Kremer M, "Discordant bone marrow involvement in diffuse large B-cell lymphoma:comparative molecular analysis reveals a heterogeneous group of disorders", Lab Invest, 83, pp.107~114 (2003)
- Howell SJ, "The value of bone marrow examination in the staging of Hodgkin’s lymphoma:a review of 955 cases seen in a regional cancer centre", Br J Haematol, 119, pp.408~411 (2002)
- 정소연, "세계보건기구 분류에 근거한 악성림프종의 골수침습 빈도 및 양상- 단일 기관 연구", Annals of Laboratory Medicine, 27(6), pp.383~387 (2007), 대한진단검사의학회
- Bartl R, "Assessment of bone marrow histology in Hodgkin’s disease: correlation with clinical factors", Br J Haematol, 51, pp.345~360 (1982)
- Swerdlow SH, "WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues" (2008), International Agency for Research on Cancer
- Bene MC, "Immunophenotyping of acute leukemia and lymphoproliferative disorders:a consensus proposal of the European LeukemiaNet Work Package 10", Leukemia, 25, pp.567~574 (2011)
- 김지명, "한국인 비호지킨림프종의 백혈병성 골수침습에 대한 임상혈액학적 소견", Laboratory Medicine Online, 1(2), pp.81~87 (2011), 대한진단검사의학회
- van Dongen JJ, "EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes", Leukemia, 26, pp.1908~1975 (2012)
- The Korean Society of Hematology, "Hematology" (2006), Epublic
- Cheson BD, "Revised response criteria for malignant lymphoma", J Clin Oncol, 25, pp.579~586 (2007)
- Thiele J, "Focal lymphoid aggregates (nodules) in bone marrow biopsies:differentiation between benign hyperplasia and malignant lymphoma: a practical guideline", J Clin Pathol, 52, pp.294~300 (1999)
- Sehn LH, "Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP", J Clin Oncol, 29, pp.1452~1457 (2011)
- Merli M, "Assessment of bone marrow involvement in non-Hodgkin’s lymphomas : comparison between histology and flow cytometry", Eur J Haematol, 85, pp.405~415 (2010)
- Campbell J, "The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement", Eur J Haematol, 76, pp.473~480 (2006)
- Conlan MG, "Bone marrow involvement by non-Hodgkin’s lymphoma:the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group", J Clin Oncol, 8, pp.1163~1172 (1990)
- Morra E, "Bone marrow and blood involvement by non-Hodgkin’s lymphoma: a study of clinicopathologic correlations and prognostic significance in relationship to the Working Formulation", Eur J Haematol, 42, pp.445~453 (1989)
- Yan Y, "Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma", J Clin Oncol, 13, pp.1336~1342 (1995)
- Ribrag V, "Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET", CT and bone marrow biopsy, 2008, pp.66, 325~331
- Kwee TC, "Imaging of bone marrow involvement in lymphoma: state of the art and future directions", ScientificWorldJournal, 11, pp.391~402 (2011)
- Hanna SL, "Magnetic resonance imaging of disseminated bone marrow disease in patients treated for malignancy", Skeletal Radiol, 20, pp.79~84 (1991)
